mono - Partners - Joint venture - but a takeover no - the R&D focus areas are too divergent and big for one entity in startup mode [and with the range of Bios that's only to continue]- in any case LK/Gunn currently holds the upper hand, unless SLA grab the ANZ held opptions 30+M then SLA will still require friendys.